Immune 2 Flashcards

1
Q

What is the equation of total arterial o2 carrying capacity in blood?

A

total = HbO2 (Hb bound) + unbound (dissolved O2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

RBC cannot use oxygen therefore goes through anaerobic glycolysis. What is a byproduct of this side reaction in RBC?

A
  • 2,3 DPG
  • diphosphoglyceric acid
  • inhibited by oxyhemoglobin HbO2
  • inverse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When HbO2 levels decrease, the production of 2,3, DPG _____?

A
  • increase when HbO2 decrease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens as a result of 2,3, DPG in RBC?

A
  • increase oxygen unloads

- curve shifts right

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many days does a RBC take to develop? Lifespan?- what does it not have?

A
- mitochondria
nucleus
ER 
- 7 days develop (recall produced in the bone marrow as a erythroblast, normoblast, reticulocyte)
- 120 days (4 mnths)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is bilirubin?

A

the product of RBC breakdown (breakdown of heme)

- RBC destroyed by the spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is bilirubin broken down?

A
  • from the spleen
  • liver enzymes bind bilirubin
  • excreted in the bile (produced in the liver)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Physiological jaundice occurs cuz (2 things)

A
  1. rapid fall in Hb in blood at birth

2. Premies have inadequate liver enzymes to bind and excrete the bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do you break down bilirubin molecules in new borns?

A

phototherapy with blue light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between alpha and beta thalassemia?

A

a: decreased synthesis of a chains
b: impaired synthesis of b chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does thalassemia cause?

A
  • excessive destruction of RBC

- stillborn, anemia, abnormalities iron overload (not binding to the RBC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is iron overload?

A

deposition around the body of iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sickle cell anemia is an inherited _____ disease.

A

recessive

- 2 copies of HbS instead of HbA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does HbS cause

A

Hb S polymerizes to long fibres
- creates sickle cells
= hemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the problem with the Rh factor situation?

A
  • mother is negative (doesnt have antigen)
  • 1st fetus is positive (has the antigen)
  • mix blood
  • Rh+ antigen (on rbc) exposed to mother
  • Mother produces anti-Rh + antibodies in response and sees it as foreign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens in the second pregnancy if the baby is also Rh+?

A
  • the mother will elicit a response to the Rh+
  • release the antiRh+ antibodies to attack the Rh+ RBC
  • causes RBC hemolytic disease of the fetus
17
Q

How is Rh-/+ treated

A
  • mother is given IV of RHIG
  • RhIG destroys the fetus blood that contains the Rh+ antigen
  • mother cannot elicit immune response to produce antibodies
18
Q

What is the common pathway for clot formation? involving what?

A

Fibrinogen is converted to fibrin via thrombin from the extrinsic pathway in vivo

19
Q

Explain the extrinsic pathway of blood clotting.

A
  • tissue factor (glycoprotein) is exposed to factor VII when injured
  • factor VII forms a complex with other factors in blood
  • complex activates factor X
  • factor X activates formation of thrombin
  • thrombin converts fibrinogen to fibrin
20
Q

How are clots dissolved?

A
  • plasminogen converted to plasmin
  • plasmin digests fibrin
  • promotes dissolution of clots
21
Q

Two types of clot dissolution drugs

A
  • TPA - tissue plasminogen activator

- fibrinolytics